$AMGN
Amgen Inc Stock $amgn

$amgn Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 8-K Financial Statement

#000031815416000055 Filed on October 31, 2016

Income Statement

Concept	2015 Q4	2014 Q4	2014 Q3
Revenue	$5.329B	$5.174B	$5.031B
YoY Change	3.0%	7.81%	5.96%
Cost Of Revenue	$1.071B	$1.183B	$1.068B
YoY Change	-9.47%	14.97%	35.53%
Gross Profit	$4.258B	$3.991B	$3.780B
YoY Change	6.69%	5.86%	-2.05%
Gross Profit Margin	79.9%	77.14%	75.13%
Selling, General & Admin	$1.416B	$1.327B	$1.213B
YoY Change	6.71%	1.61%	-2.88%
% of Gross Profit	33.26%	33.25%	32.09%
Research & Development	$1.093B	$1.234B	$1.018B
YoY Change	-11.43%	-1.2%	2.93%
% of Gross Profit	25.67%	30.92%	26.93%
Depreciation & Amortization	$542.0M	$525.0M	$543.0M
YoY Change	3.24%	18.24%	88.54%
% of Gross Profit	12.73%	13.15%	14.37%
Operating Expenses	$2.516B	$2.680B	$2.231B
YoY Change	-6.12%	3.88%	-0.31%
Operating Profit	$1.742B	$1.311B	$1.466B
YoY Change	32.88%	10.17%	-13.15%
Interest Expense	-$120.0M	-$173.0M	-$129.0M
YoY Change	-30.64%	0.0%	-30.27%
% of Operating Profit	-6.89%	-13.2%	-8.8%
Other Income/Expense, Net			$140.0M
YoY Change			94.44%
Pretax Income	$1.913B	$1.286B	$1.337B
YoY Change	48.76%	26.82%	-11.04%
Income Tax	$113.0M	-$8.000M	$93.00M
% Of Pretax Income	5.91%	-0.62%	6.96%
Net Earnings	$1.800B	$1.294B	$1.244B
YoY Change	39.1%	26.74%	-9.06%
Net Earnings / Revenue	33.78%	25.01%	24.73%
Basic Earnings Per Share	$2.39	$1.70	$1.63
Diluted Earnings Per Share	$2.37	$1.68	$1.61
COMMON SHARES
Basic Shares Outstanding	754.3M shares	760.7M shares	761.0M shares
Diluted Shares Outstanding			771.0M shares

Balance Sheet

Concept	2015 Q4	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$31.38B	$27.03B	$28.08B
YoY Change	16.12%	39.3%	24.46%
Cash & Equivalents	$4.144B	$3.731B	$3.677B
Short-Term Investments	$27.24B	$23.30B	$24.40B
Other Short-Term Assets	$1.703B	$2.492B	$2.733B
YoY Change	-31.66%	10.76%	33.38%
Inventory	$2.435B	$2.647B	$2.885B
Prepaid Expenses
Receivables	$2.995B	$2.546B	$2.355B
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$38.52B	$34.71B	$36.05B
YoY Change	10.96%	26.84%	17.52%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.907B	$5.223B	$5.267B
YoY Change	-6.05%	-2.36%	-0.3%
Goodwill	$14.75B	$14.79B	$14.82B
YoY Change	-0.25%	-1.2%	17.84%
Intangibles	$11.64B	$12.69B	$13.10B
YoY Change	-8.29%	-4.29%	255.78%
Long-Term Investments		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$1.599B	$1.467B	$1.545B
YoY Change	9.0%	-16.98%	6.55%
Total Long-Term Assets	$32.93B	$34.17B	$34.73B
YoY Change	-3.62%	-11.83%	31.55%
TOTAL ASSETS
Total Short-Term Assets	$38.52B	$34.71B	$36.05B
Total Long-Term Assets	$32.93B	$34.17B	$34.73B
Total Assets	$71.45B	$68.88B	$70.78B
YoY Change	3.73%	4.17%	24.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$965.0M	$995.0M	$955.0M
YoY Change	-3.02%	26.43%	6.7%
Accrued Expenses	$5.452B	$5.513B	$5.096B
YoY Change	-1.11%	18.43%	29.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.247B	$498.0M	$2.500B
YoY Change	351.2%	-80.12%	22627.27%
Total Short-Term Liabilities	$8.664B	$7.006B	$8.551B
YoY Change	23.67%	-11.84%	76.56%
LONG-TERM LIABILITIES
Long-Term Debt	$29.18B	$30.09B	$30.48B
YoY Change	-3.02%	1.58%	12.15%
Other Long-Term Liabilities	$1.308B	$2.547B	$6.419B
YoY Change	-48.65%	-13.98%	93.11%
Total Long-Term Liabilities	$30.49B	$32.64B	$36.90B
YoY Change	-6.58%	0.16%	1010.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.664B	$7.006B	$8.551B
Total Long-Term Liabilities	$30.49B	$32.64B	$36.90B
Total Liabilities	$39.15B	$39.64B	$45.45B
YoY Change	-1.23%	-2.19%	456.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.086B	-$4.624B	-$4.698B
YoY Change	-54.89%	-39.43%	-40.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.08B	$25.78B	$25.33B
YoY Change
Total Liabilities & Shareholders Equity	$71.45B	$68.88B	$70.78B
YoY Change	3.73%	4.17%	24.01%

Cashflow Statement

Concept	2015 Q4	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	$1.800B	$1.294B	$1.244B
YoY Change	39.1%	26.74%	-9.06%
Depreciation, Depletion And Amortization	$542.0M	$525.0M	$543.0M
YoY Change	3.24%	18.24%	88.54%
Cash From Operating Activities	$2.073B	$2.445B	$2.741B
YoY Change	-15.21%	33.24%	51.69%
INVESTING ACTIVITIES
Capital Expenditures	-$205.0M	-$338.0M	-$320.0M
YoY Change	-39.35%	68.16%	82.86%
Acquisitions
YoY Change
Other Investing Activities	-$28.00M	$712.0M	-$2.583B
YoY Change	-103.93%	-107.18%	32.87%
Cash From Investing Activities	-$233.0M	$374.0M	-$2.903B
YoY Change	-162.3%	-103.7%	37.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-922.0M	-2.765B	-513.0M
YoY Change	-66.65%	-172.63%	-118.41%
NET CHANGE
Cash From Operating Activities	2.073B	2.445B	2.741B
Cash From Investing Activities	-233.0M	374.0M	-2.903B
Cash From Financing Activities	-922.0M	-2.765B	-513.0M
Net Change In Cash	918.0M	54.00M	-675.0M
YoY Change	1600.0%	-101.21%	-127.27%
FREE CASH FLOW
Cash From Operating Activities	$2.073B	$2.445B	$2.741B
Capital Expenditures	-$205.0M	-$338.0M	-$320.0M
Free Cash Flow	$2.278B	$2.783B	$3.061B
YoY Change	-18.15%	36.69%	54.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	amgn	Accrued Liabilities Clinical Development Costs AccruedLiabilitiesClinicalDevelopmentCosts	445000000	USD
CY2015Q4	amgn	Accrued Liabilities Clinical Development Costs AccruedLiabilitiesClinicalDevelopmentCosts	491000000	USD
CY2014Q4	amgn	Accrued Sales Deductions Current AccruedSalesDeductionsCurrent	1379000000	USD
CY2015Q4	amgn	Accrued Sales Deductions Current AccruedSalesDeductionsCurrent	1486000000	USD
CY2014Q4	amgn	Accrued Sales Return Reserve Current AccruedSalesReturnReserveCurrent	361000000	USD
CY2015Q4	amgn	Accrued Sales Return Reserve Current AccruedSalesReturnReserveCurrent	390000000	USD
CY2013	amgn	Adjustmentsto Additional Paidin Capital Settlementof Conversion Valueof Convertible Debtin Excessof Principal AdjustmentstoAdditionalPaidinCapitalSettlementofConversionValueofConvertibleDebtinExcessofPrincipal	99000000	USD
CY2013	amgn	Adjustmentsto Additional Paidin Capital Settlementof Warrants AdjustmentstoAdditionalPaidinCapitalSettlementofWarrants	100000000	USD
CY2015Q4	amgn	Amount Of Common Stock Available Under Plan For Future Grants And Or Issuances AmountOfCommonStockAvailableUnderPlanForFutureGrantsAndOrIssuances	47000000	shares
CY2014Q4	amgn	Debt Instrument Unamortized Discount Premiumand Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumandDebtIssuanceCostsNet	-204000000	USD
CY2015Q4	amgn	Debt Instrument Unamortized Discount Premiumand Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumandDebtIssuanceCostsNet	-210000000	USD
CY2014Q4	amgn	Deferred Tax Assets Tax Acquired Net Operating Loss And Credit Carry Forwards DeferredTaxAssetsTaxAcquiredNetOperatingLossAndCreditCarryForwards	588000000	USD
CY2015Q4	amgn	Deferred Tax Assets Tax Acquired Net Operating Loss And Credit Carry Forwards DeferredTaxAssetsTaxAcquiredNetOperatingLossAndCreditCarryForwards	620000000	USD
CY2014Q4	amgn	Deferred Tax Assets Undistributed Foreign Earningsof Subsidiaries DeferredTaxAssetsUndistributedForeignEarningsofSubsidiaries	13000000	USD
CY2015Q4	amgn	Deferred Tax Assets Undistributed Foreign Earningsof Subsidiaries DeferredTaxAssetsUndistributedForeignEarningsofSubsidiaries	144000000	USD
CY2015Q4	amgn	Future Rental Commitments For Abandoned Leases FutureRentalCommitmentsForAbandonedLeases	327000000	USD
CY2014Q4	amgn	Identifiable Intangible Assets Accumulated Amortization IdentifiableIntangibleAssetsAccumulatedAmortization	5932000000	USD
CY2015Q4	amgn	Identifiable Intangible Assets Accumulated Amortization IdentifiableIntangibleAssetsAccumulatedAmortization	7279000000	USD
CY2014Q4	amgn	Identifiable Intangible Assets Gross IdentifiableIntangibleAssetsGross	18625000000	USD
CY2015Q4	amgn	Identifiable Intangible Assets Gross IdentifiableIntangibleAssetsGross	18920000000	USD
CY2014Q4	amgn	Laboratory Equipment LaboratoryEquipment	1240000000	USD
CY2015Q4	amgn	Laboratory Equipment LaboratoryEquipment	1140000000	USD
CY2015Q4	amgn	Long Term Debt Maturities Repayments Of Principal Net LongTermDebtMaturitiesRepaymentsOfPrincipalNet	31640000000	USD
CY2015	amgn	Number Of Common Shares Issued For Each Performance Unit Earned NumberOfCommonSharesIssuedForEachPerformanceUnitEarned	1	shares
CY2015	amgn	Number Of Common Shares To Be Reduced For Each Stock Option Granted NumberOfCommonSharesToBeReducedForEachStockOptionGranted	1	shares
CY2014	amgn	Number Of Customers Accounting For More Than Ten Percent Of Gross Trade Receivables NumberOfCustomersAccountingForMoreThanTenPercentOfGrossTradeReceivables	3	customer
CY2015	amgn	Number Of Customers Accounting For More Than Ten Percent Of Gross Trade Receivables NumberOfCustomersAccountingForMoreThanTenPercentOfGrossTradeReceivables	3	customer
CY2013	amgn	Number Of Customers Accounting For More Than Ten Percent Of Revenue NumberOfCustomersAccountingForMoreThanTenPercentOfRevenue	3	customer
CY2014	amgn	Number Of Customers Accounting For More Than Ten Percent Of Revenue NumberOfCustomersAccountingForMoreThanTenPercentOfRevenue	3	customer
CY2015	amgn	Number Of Customers Accounting For More Than Ten Percent Of Revenue NumberOfCustomersAccountingForMoreThanTenPercentOfRevenue	3	customer
CY2015	amgn	Numberof Shares Added Backfor Tax Withholdingon Full Value Awards NumberofSharesAddedBackforTaxWithholdingonFullValueAwards	1.9	shares
CY2013	amgn	Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent	-3000000	USD
CY2014	amgn	Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent	2000000	USD
CY2015	amgn	Other Comprehensive Income Loss Other Gains Losses Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossOtherGainsLossesNetOfTaxPortionAttributableToParent	9000000	USD
CY2014Q4	amgn	Other Notes OtherNotes	100000000	USD
CY2015Q4	amgn	Other Notes OtherNotes	100000000	USD
CY2013	amgn	Paymentsof Contingent Consideration Obligation PaymentsofContingentConsiderationObligation	0	USD
CY2014	amgn	Paymentsof Contingent Consideration Obligation PaymentsofContingentConsiderationObligation	92000000	USD
CY2015	amgn	Paymentsof Contingent Consideration Obligation PaymentsofContingentConsiderationObligation	253000000	USD
CY2015	amgn	Percentage Of Combined Gross Product Sales From Major Customers PercentageOfCombinedGrossProductSalesFromMajorCustomers	0.97
CY2014Q4	amgn	Percentage Of Combined Net Trade Receivables From Major Customers PercentageOfCombinedNetTradeReceivablesFromMajorCustomers	0.69
CY2015Q4	amgn	Percentage Of Combined Net Trade Receivables From Major Customers PercentageOfCombinedNetTradeReceivablesFromMajorCustomers	0.75
CY2015	amgn	Percentage Of Combined Worldwide Gross Revenues From Major Customers PercentageOfCombinedWorldwideGrossRevenuesFromMajorCustomers	0.81
CY2014Q4	amgn	Percentage Of Net Amount Due From Customers Located Outside Domestic Location PercentageOfNetAmountDueFromCustomersLocatedOutsideDomesticLocation	0.30
CY2015Q4	amgn	Percentage Of Net Amount Due From Customers Located Outside Domestic Location PercentageOfNetAmountDueFromCustomersLocatedOutsideDomesticLocation	0.23
CY2013	amgn	Rental Expense On Operating Leases RentalExpenseOnOperatingLeases	125000000	USD
CY2014	amgn	Rental Expense On Operating Leases RentalExpenseOnOperatingLeases	126000000	USD
CY2015	amgn	Rental Expense On Operating Leases RentalExpenseOnOperatingLeases	133000000	USD
CY2014	amgn	Separation Costs SeparationCosts	377000000	USD
CY2015	amgn	Separation Costs SeparationCosts	49000000	USD
CY2013	amgn	Stock Based Compensation Expense Net Of Tax StockBasedCompensationExpenseNetOfTax	254000000	USD
CY2014	amgn	Stock Based Compensation Expense Net Of Tax StockBasedCompensationExpenseNetOfTax	256000000	USD
CY2015	amgn	Stock Based Compensation Expense Net Of Tax StockBasedCompensationExpenseNetOfTax	202000000	USD
CY2013	amgn	Threshold For Disclosure Of Product Sales To Major Customers ThresholdForDisclosureOfProductSalesToMajorCustomers	0.1
CY2014	amgn	Threshold For Disclosure Of Product Sales To Major Customers ThresholdForDisclosureOfProductSalesToMajorCustomers	0.1
CY2015	amgn	Threshold For Disclosure Of Product Sales To Major Customers ThresholdForDisclosureOfProductSalesToMajorCustomers	0.1
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	8-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0000318154
CY2015	dei	Entity Registrant Name EntityRegistrantName	AMGEN INC
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	995000000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	965000000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2546000000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2995000000	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5513000000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5452000000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7033000000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7265000000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8000000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-480000000	USD
CY2013	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-42000000	USD
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-71000000	USD
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	-162000000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	99000000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	400000000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	404000000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	319000000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	642000000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000000	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	87000000	USD
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	-111000000	USD
CY2014Q4	us-gaap	Assets Assets	68882000000	USD
CY2015Q4	us-gaap	Assets Assets	71449000000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	34711000000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	38515000000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	26732000000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	31112000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	143000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	75000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	174000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	329000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	26763000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	31366000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	59000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	79000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	115000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	250000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	11642000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	20856000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1867000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1887000000	USD
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	23295000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	27238000000	USD
CY2013	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	158000000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	149000000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	132000000	USD
CY2013	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	83000000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	150000000	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	208000000	USD
CY2014Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3612000000	USD
CY2015Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	3638000000	USD
CY2014Q4	us-gaap	Cash Cash	438000000	USD
CY2015Q4	us-gaap	Cash Cash	406000000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3257000000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3805000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3731000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4144000000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	548000000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-74000000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	413000000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.47
CY2013Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.47
CY2013Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.47
CY2013Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.47
CY2014Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.61
CY2014Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.61
CY2014Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.61
CY2014Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.61
CY2015Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.79
CY2015Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.79
CY2015Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.79
CY2015Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.79
CY2015Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.00
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2750000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2750000000.0	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	760400000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	754000000	shares
CY2014Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	30410000000	USD
CY2015Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	30649000000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4774000000	USD
CY2015Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	746000000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5311000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6467000000	USD
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1183000000	USD
CY2013	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3346000000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4422000000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4227000000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	12809000000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	13872000000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	13192000000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	54000000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	251000000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1129000000	USD
CY2013	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	191000000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	194000000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	272000000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	271000000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	503000000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1441000000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	26000000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	58000000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	40000000	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	8100000000	USD
CY2014Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4500000000.0	USD
CY2015Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	3500000000.0	USD
CY2013	us-gaap	Debt Issuance Costs DebtIssuanceCosts	46000000	USD
CY2014	us-gaap	Debt Issuance Costs DebtIssuanceCosts	18000000	USD
CY2015	us-gaap	Debt Issuance Costs DebtIssuanceCosts	21000000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-86000000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-22000000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-290000000	USD
CY2013	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-20000000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-50000000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-34000000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-87000000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-76000000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-402000000	USD
CY2014Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4321000000	USD
CY2015Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3860000000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	19000000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4000000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-78000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1936000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2009000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1600000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1682000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	178000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	161000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	206000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	179000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	221000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	199000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	730000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	706000000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	336000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	327000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2721000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2178000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4089000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3633000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3461000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2239000000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	232000000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	227000000	USD
CY2015Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	11400000000	USD
CY2013	us-gaap	Depreciation Depreciation	644000000	USD
CY2014	us-gaap	Depreciation Depreciation	716000000	USD
CY2015	us-gaap	Depreciation Depreciation	727000000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1286000000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2092000000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2108000000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	438000000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	213000000	USD
CY2014Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	42000000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	261000000	USD
CY2013	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1521000000	USD
CY2014	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1995000000	USD
CY2015	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2548000000	USD
CY2014Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	601000000	USD
CY2015Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	754000000	USD
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.75
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.42
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.04
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.63
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.70
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.80
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.13
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.18
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.46
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.39
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	9.15
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.64
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.40
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.01
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.61
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.68
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.70
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.11
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.15
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.44
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.37
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	9.06
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.035
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.076
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.130
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.213
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.224
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.181
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.004
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.007
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.001
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	-0.047
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	-0.044
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Foreign EffectiveIncomeTaxRateReconciliationTaxCreditsForeign	-0.025
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.030
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.015
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.014
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.037
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0.000
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	-0.005
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	920000000	USD
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	916000000	USD
CY2013	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	149000000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	152000000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	120000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5932000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7279000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1400000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1000000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1100000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1100000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1300000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16470000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	17905000000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10538000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10626000000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	14968000000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	14788000000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	14787000000	USD
CY2014	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	-114000000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	108000000	USD
CY2014	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-66000000	USD
CY2015	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-109000000	USD
CY2014Q1	us-gaap	Gross Profit GrossProfit	3266000000	USD
CY2014Q2	us-gaap	Gross Profit GrossProfit	3868000000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	3780000000	USD
CY2014Q4	us-gaap	Gross Profit GrossProfit	3991000000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	3841000000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	4136000000	USD
CY2015Q3	us-gaap	Gross Profit GrossProfit	4482000000	USD
CY2015Q4	us-gaap	Gross Profit GrossProfit	4258000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3700000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4100000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4400000000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5265000000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5585000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7978000000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	184000000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	427000000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1039000000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	321000000	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	269000000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	919000000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	60000000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	228000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-12000000	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38000000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-136000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	420000000	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-326000000	USD
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-103000000	USD
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	509000000	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	189000000	USD
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	108000000	USD
CY2015	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	607000000	USD
CY2013	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7000000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-327000000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-481000000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	59000000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1000000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-155000000	USD
CY2013	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	116000000	USD
CY2014	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	759000000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	402000000	USD
CY2013	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	520000000	USD
CY2014	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	-533000000	USD
CY2015	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	0	USD
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12693000000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11641000000	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	1022000000	USD
CY2014	us-gaap	Interest Expense Debt InterestExpenseDebt	1071000000	USD
CY2015	us-gaap	Interest Expense Debt InterestExpenseDebt	1095000000	USD
CY2013	us-gaap	Interest Paid InterestPaid	1100000000	USD
CY2014	us-gaap	Interest Paid InterestPaid	1100000000	USD
CY2015	us-gaap	Interest Paid InterestPaid	1000000000	USD
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	898000000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	705000000	USD
CY2014Q4	us-gaap	Inventory Net InventoryNet	2647000000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	2435000000	USD
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	198000000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	201000000	USD
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1551000000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1529000000	USD
CY2014Q4	us-gaap	Land Land	398000000	USD
CY2015Q4	us-gaap	Land Land	319000000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68882000000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71449000000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7006000000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8664000000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	30588000000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	31429000000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	498000000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2247000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	17682000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2250000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1950000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	3383000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	2075000000	USD
CY2015Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4300000000	USD
CY2014Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	30090000000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29182000000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1711000000	USD
CY2015Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2051000000	USD
CY2015	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P3Y
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2491000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6526000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3274000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3771000000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8469000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5752000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5547000000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	8952000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9731000000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	5081000000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	1073000000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	1547000000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	1244000000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	1294000000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	5158000000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	1623000000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	1653000000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	1863000000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	1800000000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	6939000000	USD
CY2013	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	420000000	USD
CY2014	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	465000000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	603000000	USD
CY2014Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	33600000000	USD
CY2015Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	33100000000	USD
CY2015	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	5867000000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	6191000000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	8470000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	749000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	127000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	98000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	101000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	107000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	117000000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	199000000	USD
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1807000000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1415000000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2492000000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1703000000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1467000000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1599000000	USD
CY2013	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-226000000	USD
CY2014	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	24000000	USD
CY2015	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-241000000	USD
CY2013	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	2000000	USD
CY2014	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	323000000	USD
CY2015	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParent	7000000	USD
CY2013	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-80000000	USD
CY2014	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-196000000	USD
CY2015	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-247000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-307000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	153000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-472000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-307000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	153000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-472000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	28000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	0	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	-18000000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	33000000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	-74000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	53000000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	34000000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	104000000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	53000000	USD
CY2013	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-105000000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	14000000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2013	us-gaap	Other General Expense OtherGeneralExpense	196000000	USD
CY2014	us-gaap	Other General Expense OtherGeneralExpense	454000000	USD
CY2015	us-gaap	Other General Expense OtherGeneralExpense	49000000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2547000000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3281000000	USD
CY2013	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-199000000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-56000000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	146000000	USD
CY2014	us-gaap	Other Restructuring Costs OtherRestructuringCosts	39000000	USD
CY2015	us-gaap	Other Restructuring Costs OtherRestructuringCosts	76000000	USD
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	484000000	USD
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	736000000	USD
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	718000000	USD
CY2013	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	90000000	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	138000000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	392000000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	832000000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	138000000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1867000000	USD
CY2014	us-gaap	Payments For Restructuring PaymentsForRestructuring	141000000	USD
CY2015	us-gaap	Payments For Restructuring PaymentsForRestructuring	258000000	USD
CY2013	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1415000000	USD
CY2014	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1851000000	USD
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2396000000	USD
CY2013	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	139000000	USD
CY2014	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	225000000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	401000000	USD
CY2013	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	21965000000	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	25878000000	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	25977000000	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9434000000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	165000000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	359000000	USD
CY2013	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	285000000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	55000000	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	693000000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	718000000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	594000000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	8054000000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4476000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3465000000	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	296000000	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	186000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	82000000	USD
CY2013	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	5090000000	USD
CY2014	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	4199000000	USD
CY2015	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3527000000	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-102000000	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-25000000	USD
CY2015	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
CY2013	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	19123000000	USD
CY2014	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	16697000000	USD
CY2015	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	18029000000	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	20000000	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000000	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	274000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12256000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12172000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5223000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4907000000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4112000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4278000000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3371000000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5605000000	USD
CY2015	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2400000000	USD
CY2014	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5600000000	USD
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4083000000	USD
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4297000000	USD
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4070000000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	385000000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	132000000	USD
CY2014	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	558000000	USD
CY2015	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	114000000	USD
CY2013Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2014Q4	us-gaap	Restructuring Reserve RestructuringReserve	244000000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	118000000	USD
CY2014	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	55000000	USD
CY2015	us-gaap	Restructuring Reserve Accelerated Depreciation RestructuringReserveAcceleratedDepreciation	100000000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4624000000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2086000000	USD
CY2013	us-gaap	Revenues Revenues	18676000000	USD
CY2014	us-gaap	Revenues Revenues	20063000000	USD
CY2015	us-gaap	Revenues Revenues	21662000000	USD
CY2013	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	18192000000	USD
CY2014Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4356000000	USD
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4949000000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4848000000	USD
CY2014Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5174000000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	19327000000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4874000000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5225000000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5516000000	USD
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5329000000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	20944000000	USD
CY2013	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5184000000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4699000000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4846000000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	403000000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	408000000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	322000000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	RSUs generally vest in approximately equal amounts on the second, third and fourth anniversaries of the grant date.
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	296000000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	186000000	USD
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	82000000	USD
CY2015Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4900000000	USD
CY2015Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	5000000000	USD
CY2013	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	771000000	USD
CY2014	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	153000000	USD
CY2015	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1853000000	USD
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	9100000	shares
CY2013Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2013Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2013Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2013	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	9100000	shares
CY2014Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2014Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2014Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2014Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	900000	shares
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	22000000	USD
CY2014	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	900000	shares
CY2015Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	2900000	shares
CY2015Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3300000	shares
CY2015Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	4600000	shares
CY2015Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1200000	shares
CY2015	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	12000000	shares
CY2013Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	771000000	USD
CY2013Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2013Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2013Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2013	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	771000000	USD
CY2014Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2014Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2014Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2014Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	153000000	USD
CY2014	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	153000000	USD
CY2015Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	451000000	USD
CY2015Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	515000000	USD
CY2015Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	703000000	USD
CY2015Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	184000000	USD
CY2015	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1853000000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	19060000000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	22096000000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	25778000000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	28083000000	USD
CY2015Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	32600000000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1200000000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1415000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1772000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2114000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	192000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	45000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	32000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	24000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	2000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	48000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	134000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	151000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	32000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	35000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	17000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	335000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	379000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	413000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	96000000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9000000	USD
CY2012Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	61000000	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	59000000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	50000000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	55000000	USD
CY2013	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	5000000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	37000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	9000000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	12000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2014	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	3000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	18000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	0	USD
CY2013	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	7000000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	12000000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	13000000	USD
CY2013	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	12000000	shares
CY2014	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	11000000	shares
CY2015	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	8000000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	765000000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	770000000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	766000000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	753000000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	759000000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	758000000	shares
CY2015	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain of our short-term obligations were reclassified from Accounts payable to Accrued liabilities on our Consolidated Balance Sheet at December 31, 2014, and related amounts within Net cash provided by operating activities in our Consolidated Statements of Cash Flows for the years ended December 31, 2014 and 2013, to conform to the current year presentation.</font></div></div>
CY2015	us-gaap	Revenue Recognition Multiple Element Arrangements RevenueRecognitionMultipleElementArrangements	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Multiple-deliverable revenue arrangements</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From time to time, we enter into arrangements for the R&D, manufacture and/or commercialization of products and product candidates. These arrangements may require us to deliver various rights, services and/or goods across the entire life cycle of a product or product candidate, including (i) intellectual property rights/licenses, (ii) R&D services, (iii) manufacturing services and/or (iv) commercialization services. The underlying terms of these arrangements generally provide for consideration to Amgen in the form of non-refundable upfront license payments, R&D and commercial performance milestone payments, cost sharing and/or royalty payments.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In arrangements involving the delivery of more than one element, each required deliverable is evaluated to determine whether it qualifies as a separate unit of accounting. For Amgen, this determination is generally based on whether the deliverable has “stand-alone value” to the customer. The arrangement’s consideration that is fixed and determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. The estimated selling price of each deliverable is determined using the following hierarchy of values: (i) vendor-specific objective evidence of fair value, (ii) third-party evidence of selling price and (iii) best estimate of selling price (BESP). The BESP reflects our best estimate of what the selling price would be if the deliverable was regularly sold by us on a stand-alone basis. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent upon future deliverables. Consideration associated with at-risk substantive performance milestones is recognized as revenue upon the achievement of the related milestone, as defined in the respective contracts.</font></div></div>
CY2015	us-gaap	Revenue Recognition Sales Of Goods RevenueRecognitionSalesOfGoods	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Product sales</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales of our products are recognized when shipped and title and risk of loss have passed. Product sales are recorded net of accruals for estimated rebates, wholesaler chargebacks, discounts and other deductions (collectively “sales deductions”) and returns. Taxes collected from customers and remitted to government authorities related to the sales of the Company’s products, primarily in Europe, are excluded from revenues.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We recognized revenue from the sale of product to the U.S. federal government for stockpile in accordance with U.S. Securities and Exchange Commission (SEC) Interpretation,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Commission Guidance Regarding Accounting for Sales of Vaccines and Bioterror Countermeasures to the Federal Government for Placement into the Pediatric Vaccine Stockpile or the Strategic National Stockpile</font><font style="font-family:inherit;font-size:10pt;"> (SNS). We recognized </font><font style="font-family:inherit;font-size:10pt;">$155 million</font><font style="font-family:inherit;font-size:10pt;"> of revenue for NEUPOGEN</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> during the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, for purchases by the federal government for the SNS. There were no purchases by the federal government for the SNS during the years ended December 31, 2015 and 2014. We are contracted to manage this inventory of product until the federal government requests shipment.</font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of estimates</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0000318154-16-000055-index-headers.html	Edgar Link	pending
0000318154-16-000055-index.html	Edgar Link	pending
0000318154-16-000055.txt	Edgar Link	pending
0000318154-16-000055-xbrl.zip	Edgar Link	pending
amgn-20161026.xml	Edgar Link	completed
amgn-20161026.xsd	Edgar Link	pending
amgn-20161026_cal.xml	Edgar Link	unprocessable
amgn-20161026_def.xml	Edgar Link	unprocessable
amgn-20161026_lab.xml	Edgar Link	unprocessable
amgn-20161026_pre.xml	Edgar Link	unprocessable
amgn8k.htm	Edgar Link	pending
exhibit23.htm	Edgar Link	pending
exhibit991.htm	Edgar Link	pending
exhibit992.htm	Edgar Link	pending
exhibit993.htm	Edgar Link	pending
exhibit994.htm	Edgar Link	pending
exhibit995.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMGN
Amgen Inc Stock $amgn

2015 Q4 Form 8-K Financial Statement

#000031815416000055 Filed on October 31, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMGN Amgen Inc Stock $amgn

2015 Q4 Form 8-K Financial Statement

#000031815416000055 Filed on October 31, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMGN
Amgen Inc Stock $amgn